# The Efficacy of Three Different Limus Agent-Eluting Stents to Prevent Restenosis

> **NCT00332397** · PHASE4 · COMPLETED · sponsor: **Deutsches Herzzentrum Muenchen** · enrollment: 1007 (actual)

## Conditions studied

- Coronary Disease

## Interventions

- **DEVICE:** Rapamycin-eluting Stent
- **DEVICE:** Zotarolimus-eluting Stent
- **DEVICE:** Rapamycin-eluting Stent

## Key facts

- **NCT ID:** NCT00332397
- **Lead sponsor:** Deutsches Herzzentrum Muenchen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 1007 (ACTUAL)
- **Last updated:** 2008-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00332397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00332397, "The Efficacy of Three Different Limus Agent-Eluting Stents to Prevent Restenosis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00332397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*